$ACHN Recent News U.S. stock futures sink on shu
Post# of 145157
Posted On: 01/25/2014 12:52:46 PM
$ACHN Recent News
U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 9:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 9:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 11:56 a.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 4:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Gilead shares boosted by Bristol-Myers drug news 10:24 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Bristol-Myers falls 7% on hepatitis C drug setback 9:09 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Stocks to watch Thursday: Annie’s, Rite Aid 4:02 p.m. June 6, 2012 - David B. Wilkerson
Achillion's chief medical officer resigns 3:19 p.m. June 6, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:23 p.m. May 21, 2012 - MarketWatch
Achillion jumps on hepatitis C study 2:22 p.m. May 21, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:26 p.m. April 19, 2012 - MarketWatch
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 5:27 a.m. Jan. 13, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape 9:04 a.m. Jan. 9, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Exelixis (EXEL) Jumps: Stock Moves 11.1% Higher - Tale of the Tape 9:25 a.m. Jan. 7, 2014 - Zacks.com
Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape 9:04 a.m. Jan. 7, 2014 - Zacks.com
AxoGen (AXGN) in Focus: Stock Surges 25.0% - Tale of the Tape 9:46 a.m. Jan. 2, 2014 - Zacks.com
Commit To Buy Achillion Pharmaceuticals At $2.50, Earn 24% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Top Insider Trades: SIGM, GBDC, ADC, ACHN 5:05 p.m. Dec. 25, 2013 - TheStreet.com
Good Luck Chasing Celldex 6:00 a.m. Dec. 18, 2013 - TheStreet.com
Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape 9:04 a.m. Dec. 17, 2013 - Zacks.com
Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape 8:55 a.m. Dec. 12, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference Transcript 6:19 p.m. Dec. 11, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:00 a.m. Dec. 11, 2013 - InvestorPlace.com
Bad News Biotechs Of 2013 7:00 a.m. Dec. 10, 2013 - Seeking Alpha
Achillion Pharmaceuticals, Inc. (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 7:41 a.m. Dec. 5, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 6:30 p.m. Dec. 4, 2013 - Seeking Alpha
BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape 8:37 a.m. Dec. 4, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 5:15 a.m. Dec. 4, 2013 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:38 a.m. Dec. 2, 2013 - benzinga.com
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 6:25 a.m. Jan. 13, 2014 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 11:53 a.m. Dec. 6, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:01 a.m. Dec. 2, 2013 - ACCESSWIRE
Achillion to Present at the Three Upcoming Healthcare Conferences 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 1:21 p.m. Nov. 22, 2013 - BusinessWire
SAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Achillion Pharmaceutical, Inc. and Certain Officers - ACLN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 3:58 p.m. Nov. 13, 2013 - GlobeNewswire
Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results 6:05 a.m. Nov. 12, 2013 - GlobeNewswire
Achillion to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 11, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Investors with More Than $150,000 in Losses from Investments in Achillion Pharmaceuticals, Inc. Are Encouraged to Contact Wolf Haldenstein before the December 9, 2013 Lead Plaintiff Deadline 12:38 p.m. Nov. 7, 2013 - BusinessWire
Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 8:05 a.m. Nov. 2, 2013 - GlobeNewswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Achillion Pharmaceuticals, Inc. 8:01 a.m. Oct. 31, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Achillion Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline -- ACLN 1:54 p.m. Oct. 25, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 10:40 a.m. Oct. 25, 2013 - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Achillion Pharmaceuticals, Inc. Investors 3:12 p.m. Oct. 24, 2013 - BusinessWire
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Achillion Pharmaceuticals, Inc. 11:05 a.m. Oct. 17, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE
U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 9:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 9:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 11:56 a.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 4:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Gilead shares boosted by Bristol-Myers drug news 10:24 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Bristol-Myers falls 7% on hepatitis C drug setback 9:09 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Stocks to watch Thursday: Annie’s, Rite Aid 4:02 p.m. June 6, 2012 - David B. Wilkerson
Achillion's chief medical officer resigns 3:19 p.m. June 6, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:23 p.m. May 21, 2012 - MarketWatch
Achillion jumps on hepatitis C study 2:22 p.m. May 21, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:26 p.m. April 19, 2012 - MarketWatch
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 5:27 a.m. Jan. 13, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape 9:04 a.m. Jan. 9, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Exelixis (EXEL) Jumps: Stock Moves 11.1% Higher - Tale of the Tape 9:25 a.m. Jan. 7, 2014 - Zacks.com
Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape 9:04 a.m. Jan. 7, 2014 - Zacks.com
AxoGen (AXGN) in Focus: Stock Surges 25.0% - Tale of the Tape 9:46 a.m. Jan. 2, 2014 - Zacks.com
Commit To Buy Achillion Pharmaceuticals At $2.50, Earn 24% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Top Insider Trades: SIGM, GBDC, ADC, ACHN 5:05 p.m. Dec. 25, 2013 - TheStreet.com
Good Luck Chasing Celldex 6:00 a.m. Dec. 18, 2013 - TheStreet.com
Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape 9:04 a.m. Dec. 17, 2013 - Zacks.com
Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape 8:55 a.m. Dec. 12, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference Transcript 6:19 p.m. Dec. 11, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:00 a.m. Dec. 11, 2013 - InvestorPlace.com
Bad News Biotechs Of 2013 7:00 a.m. Dec. 10, 2013 - Seeking Alpha
Achillion Pharmaceuticals, Inc. (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 7:41 a.m. Dec. 5, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 6:30 p.m. Dec. 4, 2013 - Seeking Alpha
BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape 8:37 a.m. Dec. 4, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 5:15 a.m. Dec. 4, 2013 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:38 a.m. Dec. 2, 2013 - benzinga.com
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 6:25 a.m. Jan. 13, 2014 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 11:53 a.m. Dec. 6, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:01 a.m. Dec. 2, 2013 - ACCESSWIRE
Achillion to Present at the Three Upcoming Healthcare Conferences 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 1:21 p.m. Nov. 22, 2013 - BusinessWire
SAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Achillion Pharmaceutical, Inc. and Certain Officers - ACLN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 3:58 p.m. Nov. 13, 2013 - GlobeNewswire
Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results 6:05 a.m. Nov. 12, 2013 - GlobeNewswire
Achillion to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 11, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Investors with More Than $150,000 in Losses from Investments in Achillion Pharmaceuticals, Inc. Are Encouraged to Contact Wolf Haldenstein before the December 9, 2013 Lead Plaintiff Deadline 12:38 p.m. Nov. 7, 2013 - BusinessWire
Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 8:05 a.m. Nov. 2, 2013 - GlobeNewswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Achillion Pharmaceuticals, Inc. 8:01 a.m. Oct. 31, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Achillion Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline -- ACLN 1:54 p.m. Oct. 25, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 10:40 a.m. Oct. 25, 2013 - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Achillion Pharmaceuticals, Inc. Investors 3:12 p.m. Oct. 24, 2013 - BusinessWire
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Achillion Pharmaceuticals, Inc. 11:05 a.m. Oct. 17, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE
(0)
(0)